We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CT Radiation Dose Reduced by 95% Using Image-Processing Algorithm

By HospiMedica International staff writers
Posted on 17 Aug 2010
Perfusion CT scanning, an emerging imaging technology, received bad press in 2009 when a machine set to incorrect radiation levels overdosed hundreds of people in Los Angeles (CA, USA). More...
In the wake of that incident, researchers excited by the technology's potential for diagnosing stroke, cancer, and possibly heart disease, have developed a method to reduce the amount of radiation involved in the procedure, which, when performed correctly, already involves very little risk.

"At the correct dose, there should be no injury,” said Dr. Cynthia McCollough, from at the Mayo Clinic (Rochester, MN, USA). "We believe in the clinical value of perfusion CT, so we're trying to lower the dose and reduce the stigma.” Dr. McCollough and her colleagues created a new image-processing algorithm that can give radiologists all of the information they need using as up to 20 times less radiation, depending on the diagnostic application. The research was presented July 20, 2010, at the 52nd annual meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia PA, USA.

A typical CT perfusion procedure lasts approximately half a minute and scans the same tissue many times, each scan at a low dose. These scans both reveal the internal anatomy of the patient and show how levels of a contrast agent, such as iodine injected into the bloodstream, change of over time. Changing concentrations of iodine can be used to calculate blood volume and flow in order to detect injuries to blood vessels or tumor responses to treatment.

The new adaptive algorithm compares these 20-30 scans and can distinguish between anatomic regions that do not change from moment to moment and those regions that carry the contrast agent--effectively reducing image noise while preserving iodine signal. The quality of each scan improves through nonlinear comparisons with scans acquired earlier and later in the exam.

"When we use very low doses, the noise gets so high that it's hard to tell what you are seeing,” said Dr. Juan Carlos Ramirez Giraldo. "With this algorithm, we're trying to maintain both the image quality, so that a doctor can recognize the anatomic structures, and the functional information, which is conveyed by analyzing the flow of the contrast agent over the many low dose scans.”

At the AAPM meeting, the researchers presented animal data showing the effectiveness of the technique. They have also started to process data from clinical brain perfusion CT exams in patients. "We're up to 15 or 20 cases that we've shown to the docs, and they're all giving us the thumbs up,” said Dr. McCollough.

Related Links:

Mayo Clinic



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Pediatric Mask
Respire SOFT
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.